Landmark Bank’s Amgen AMGN Stock Holding History

Landmark Bank’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$253K	Sell	1,048 -14	-1%	-$3.09K	0.06%	85
2019 Q3	$206K	Buy	+1,062	New	+$204K	0.13%	92

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Landmark Bank's AMGN Position: Q4 2019 in Review

Landmark Bank reduced its Amgen (AMGN) stake by 1.3% in Q4 2019, selling an estimated $3.09K and leaving 1,048 shares worth $253K. The position accounts for 0.06% of the portfolio, ranked #85.

Landmark Bank first reported a position in AMGN in Q3 2019 and has held it in 2 quarters since. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

Landmark Bank held 1,048 shares of Amgen worth $253K as of Q4 2019.
Landmark Bank sold 14 Amgen shares in Q4 2019, an estimated $3.09K.
Amgen made up 0.06% of Landmark Bank's portfolio in Q4 2019, its #85 holding.
Landmark Bank first reported a position in Amgen in Q3 2019 and has held it in 2 quarters since.
2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Landmark Bank's 13F filing for Q4 2019, filed 12 Feb 2020.